|
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.914 EUR | -1.14% |
|
+3.57% | -1.69% |
| 12-12 | European markets positive, Mib above 44,000 points | AN |
| 12-11 | Lagfin Nears Tax Settlement, Bringing Relief to Campari | AN |
| Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 4.04 | 5.44 | 6.3 | 5.92 | 4.9 | |||||
Return on Total Capital | 5.02 | 6.84 | 8 | 7.39 | 6.01 | |||||
Return On Equity % | 8.52 | 12.94 | 13.13 | 11.87 | 5.68 | |||||
Return on Common Equity | 8.57 | 13.04 | 13.2 | 11.8 | 5.95 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 57.9 | 59.69 | 58.89 | 58.25 | 57.55 | |||||
SG&A Margin | 39.74 | 39.66 | 37.77 | 37.67 | 38.21 | |||||
EBITDA Margin % | 19.97 | 21.71 | 22.98 | 23.25 | 22.37 | |||||
EBITA Margin % | 17.29 | 19.47 | 20.88 | 20.69 | 19.45 | |||||
EBIT Margin % | 17.12 | 19.32 | 20.75 | 20.59 | 19.35 | |||||
Income From Continuing Operations Margin % | 10.55 | 13.03 | 12.29 | 11.39 | 6.27 | |||||
Net Income Margin % | 10.6 | 13.11 | 12.34 | 11.32 | 6.57 | |||||
Net Avail. For Common Margin % | 10.6 | 13.11 | 12.34 | 11.32 | 6.57 | |||||
Normalized Net Income Margin | 10.01 | 11.79 | 12.16 | 11.03 | 9.36 | |||||
Levered Free Cash Flow Margin | 11.11 | 10.87 | -1.59 | -9.69 | -10.41 | |||||
Unlevered Free Cash Flow Margin | 12.36 | 11.68 | -0.86 | -8.17 | -8.16 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.38 | 0.45 | 0.49 | 0.46 | 0.41 | |||||
Fixed Assets Turnover | 3.07 | 3.6 | 3.65 | 3.04 | 2.39 | |||||
Receivables Turnover (Average Receivables) | 5.9 | 7.59 | 9.01 | 8.55 | 7.67 | |||||
Inventory Turnover (Average Inventory) | 1.17 | 1.25 | 1.27 | 1.08 | 0.88 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 2.06 | 2.02 | 2 | 1.98 | 2.37 | |||||
Quick Ratio | 1.16 | 1.21 | 0.89 | 0.91 | 0.96 | |||||
Operating Cash Flow to Current Liabilities | 0.36 | 0.51 | 0.41 | 0.13 | 0.54 | |||||
Days Sales Outstanding (Average Receivables) | 62.06 | 48.06 | 40.52 | 42.68 | 47.7 | |||||
Days Outstanding Inventory (Average Inventory) | 312.36 | 292.57 | 287.98 | 339.12 | 415.1 | |||||
Average Days Payable Outstanding | 130.92 | 135.62 | 124.94 | 132.9 | 124.58 | |||||
Cash Conversion Cycle (Average Days) | 243.5 | 205.01 | 203.56 | 248.89 | 338.21 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 83.08 | 69.21 | 76.78 | 85.59 | 79.43 | |||||
Total Debt / Total Capital | 45.38 | 40.9 | 43.43 | 46.12 | 44.27 | |||||
LT Debt/Equity | 69.26 | 55.65 | 71.69 | 68.89 | 70.56 | |||||
Long-Term Debt / Total Capital | 37.83 | 32.89 | 40.55 | 37.12 | 39.32 | |||||
Total Liabilities / Total Assets | 56.13 | 53.37 | 55.45 | 56.16 | 54.55 | |||||
EBIT / Interest Expense | 8.57 | 14.83 | 17.77 | 8.49 | 5.39 | |||||
EBITDA / Interest Expense | 10.44 | 17.19 | 20.16 | 9.82 | 6.41 | |||||
(EBITDA - Capex) / Interest Expense | 8.46 | 12.92 | 9.41 | 5.67 | 2.55 | |||||
Total Debt / EBITDA | 4.49 | 3.38 | 3.24 | 3.6 | 4.34 | |||||
Net Debt / EBITDA | 3.01 | 1.72 | 2.53 | 2.69 | 3.39 | |||||
Total Debt / (EBITDA - Capex) | 5.54 | 4.5 | 6.94 | 6.24 | 10.9 | |||||
Net Debt / (EBITDA - Capex) | 3.71 | 2.3 | 5.42 | 4.66 | 8.5 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | -3.83 | 22.61 | 24.16 | 8.19 | 5.18 | |||||
Gross Profit, 1 Yr. Growth % | -8.5 | 26.42 | 22.49 | 7.02 | 3.92 | |||||
EBITDA, 1 Yr. Growth % | -22.86 | 39.51 | 31.37 | 11.7 | 0.64 | |||||
EBITA, 1 Yr. Growth % | -26.16 | 45.65 | 33.08 | 9.6 | -1.71 | |||||
EBIT, 1 Yr. Growth % | -24.28 | 45.97 | 33.29 | 9.74 | -1.72 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | -39.4 | 51.42 | 17.14 | 0.3 | -42.08 | |||||
Net Income, 1 Yr. Growth % | -39.07 | 51.57 | 16.92 | -0.75 | -39 | |||||
Normalized Net Income, 1 Yr. Growth % | -23.96 | 64.12 | 28.03 | 0.45 | -11.3 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | -38.46 | 56.25 | 16 | 0 | -42.09 | |||||
Accounts Receivable, 1 Yr. Growth % | -11.69 | 3.05 | 6.23 | 21.45 | 13.76 | |||||
Inventory, 1 Yr. Growth % | 6.47 | 13.28 | 34.68 | 23.8 | 35.98 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | -5.06 | 14.63 | 29.2 | 21.39 | 44.19 | |||||
Total Assets, 1 Yr. Growth % | -5.85 | 11.77 | 17.95 | 10.98 | 27.08 | |||||
Tangible Book Value, 1 Yr. Growth % | 340.2 | -79.52 | 541.55 | -68.57 | -133.24 | |||||
Common Equity, 1 Yr. Growth % | -16.34 | 18.79 | 12.78 | 9.3 | 31.75 | |||||
Cash From Operations, 1 Yr. Growth % | -25.01 | 73.93 | -21.36 | -58.86 | 328.43 | |||||
Capital Expenditures, 1 Yr. Growth % | -24.02 | 73.1 | 179.83 | -13.35 | 44.58 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | 3.74 | 27.38 | -118.18 | 396.05 | 13.85 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | 1.76 | 22.32 | -109.17 | 539.2 | 6.05 | |||||
Dividend Per Share, 1 Yr. Growth % | 0 | 9.09 | 0 | 8.33 | 0 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 1.75 | 8.59 | 23.38 | 15.9 | 6.67 | |||||
Gross Profit, 2 Yr. CAGR % | -0.11 | 7.55 | 24.44 | 14.49 | 5.46 | |||||
EBITDA, 2 Yr. CAGR % | -13.56 | 1.4 | 35.4 | 19.94 | 6.3 | |||||
EBITA, 2 Yr. CAGR % | -15.75 | 1 | 39.24 | 19.46 | 4.09 | |||||
EBIT, 2 Yr. CAGR % | -14.99 | 2.36 | 39.5 | 19.62 | 4.15 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | -20.58 | -4.21 | 33.18 | 8.39 | -23.78 | |||||
Net Income, 2 Yr. CAGR % | -20.37 | -3.9 | 33.12 | 7.72 | -22.19 | |||||
Normalized Net Income, 2 Yr. CAGR % | -14.8 | 4.83 | 44.96 | 12.08 | -5.29 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | -20 | -1.94 | 34.63 | 7.7 | -23.9 | |||||
Accounts Receivable, 2 Yr. CAGR % | -0.72 | -4.6 | 4.63 | 13.53 | 17.54 | |||||
Inventory, 2 Yr. CAGR % | 7.71 | 9.95 | 23.52 | 29.6 | 29.75 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 11.16 | 4.36 | 21.7 | 27.7 | 32.3 | |||||
Total Assets, 2 Yr. CAGR % | -0.3 | 2.6 | 14.82 | 14.49 | 18.76 | |||||
Tangible Book Value, 2 Yr. CAGR % | 27.46 | -5.16 | 14.63 | 36.87 | -67.68 | |||||
Common Equity, 2 Yr. CAGR % | -3.92 | -0.31 | 15.75 | 11.06 | 20 | |||||
Cash From Operations, 2 Yr. CAGR % | -8.83 | 15.43 | 16.96 | -43.12 | 32.76 | |||||
Capital Expenditures, 2 Yr. CAGR % | -8.12 | 14.68 | 120.09 | 55.72 | 11.93 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | -5.92 | 11.55 | -51.86 | 9.38 | 136.73 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | -5.15 | 8.61 | -66.5 | -3.11 | 159.16 | |||||
Dividend Per Share, 2 Yr. CAGR % | 4.88 | 4.45 | 4.45 | 4.08 | 4.08 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 0.35 | 8.27 | 13.55 | 18.1 | 12.21 | |||||
Gross Profit, 3 Yr. CAGR % | 0.45 | 8.05 | 12.32 | 18.34 | 10.85 | |||||
EBITDA, 3 Yr. CAGR % | -9.48 | -0.13 | 10.55 | 26.15 | 13.32 | |||||
EBITA, 3 Yr. CAGR % | -10.82 | -0.65 | 10.73 | 27.63 | 12.15 | |||||
EBIT, 3 Yr. CAGR % | -10.28 | 0 | 11.78 | 27.83 | 12.25 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | -19.36 | -1.52 | 2.44 | 21.17 | -12.04 | |||||
Net Income, 3 Yr. CAGR % | -19.22 | -1.31 | 2.59 | 20.71 | -10.88 | |||||
Normalized Net Income, 3 Yr. CAGR % | -9.11 | 1.61 | 12.05 | 27.27 | 3.9 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | -18.9 | 0 | 3.71 | 21.93 | -12.42 | |||||
Accounts Receivable, 3 Yr. CAGR % | -3.9 | 0.52 | -1.12 | 9.92 | 13.61 | |||||
Inventory, 3 Yr. CAGR % | 10.12 | 9.62 | 17.64 | 23.91 | 31.69 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 9.22 | 12.33 | 12.06 | 23.19 | 32.98 | |||||
Total Assets, 3 Yr. CAGR % | 1.02 | 3.58 | 7.48 | 13.57 | 18.54 | |||||
Tangible Book Value, 3 Yr. CAGR % | -2.94 | -30.76 | 79.37 | -27.34 | -14.61 | |||||
Common Equity, 3 Yr. CAGR % | 0.92 | 3.12 | 3.88 | 13.58 | 17.56 | |||||
Cash From Operations, 3 Yr. CAGR % | -4.37 | 13.88 | 1.57 | -17.44 | 11.5 | |||||
Capital Expenditures, 3 Yr. CAGR % | -6.6 | 13.48 | 54.39 | 61.31 | 51.91 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | -0.32 | 2.01 | -39.05 | 15.1 | 10.56 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | -0.47 | 1.4 | -52.35 | 4.74 | -0.45 | |||||
Dividend Per Share, 3 Yr. CAGR % | 3.23 | 6.27 | 2.94 | 5.73 | 2.7 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 1.35 | 4.7 | 9 | 11.26 | 10.75 | |||||
Gross Profit, 5 Yr. CAGR % | 2.27 | 5.66 | 9.43 | 10.58 | 9.52 | |||||
EBITDA, 5 Yr. CAGR % | -1.65 | 3.19 | 5.37 | 7.46 | 8.4 | |||||
EBITA, 5 Yr. CAGR % | -2.46 | 3.16 | 5.45 | 6.95 | 7.55 | |||||
EBIT, 5 Yr. CAGR % | -2.09 | 3.68 | 5.91 | 7.43 | 8.19 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 1.21 | 11.22 | -1.44 | 2.33 | -8.99 | |||||
Net Income, 5 Yr. CAGR % | 1.39 | 11.36 | -1.35 | 2.21 | -8.15 | |||||
Normalized Net Income, 5 Yr. CAGR % | 0.55 | 6.61 | 6.79 | 5.67 | 4.27 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 1.3 | 12.3 | -0.68 | 3.01 | -8.37 | |||||
Accounts Receivable, 5 Yr. CAGR % | -0.97 | -1.06 | -0.57 | 5.54 | 5.94 | |||||
Inventory, 5 Yr. CAGR % | 5.68 | 6.53 | 15.35 | 17.21 | 22.52 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 4.07 | 4.52 | 14.07 | 18.24 | 20.69 | |||||
Total Assets, 5 Yr. CAGR % | 1.52 | 2.28 | 6.33 | 7.81 | 11.88 | |||||
Tangible Book Value, 5 Yr. CAGR % | 13.98 | -34.68 | 3.69 | -9.06 | -10.95 | |||||
Common Equity, 5 Yr. CAGR % | 2.72 | 4.54 | 6.61 | 6.23 | 10.06 | |||||
Cash From Operations, 5 Yr. CAGR % | -2.26 | 4.11 | 4.1 | -13.73 | 13.06 | |||||
Capital Expenditures, 5 Yr. CAGR % | 5.14 | 13.66 | 31.6 | 28.79 | 35.76 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 1.65 | 9.33 | -26.39 | 4.91 | 10.97 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | -0.24 | 5.51 | -36.31 | -0.41 | 3.09 | |||||
Dividend Per Share, 5 Yr. CAGR % | 4.1 | 5.92 | 3.71 | 5.39 | 3.4 |
- Stock Market
- Equities
- CPR Stock
- Financials Davide Campari-Milano N.V.
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















